Single-blinded randomized investigator-initiated controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy with myocarditis (chronic inflammatory cardiomyopathy) – Trial and Registry to study the role of genotype environment interaction in Chronic myocarditis and inflammatory cardiomyopathies with ventricular pro-arrhythmic and heart failure phenotypes (PNRR-MAD-2022-12376225)
This research study is investigating a medicine called colchicine for people who have an inflammatory heart condition known as inflammatory cardiomyopathy. This condition means the heart muscle is inflamed, which can affect how well it pumps blood. The main goal is to find out if colchicine can help prevent the condition from getting worse over a six-month period. Researchers will check if people taking the medicine are alive and show improvements in their heart health, such as better heart function or fewer irregular heartbeats. They will also monitor whether the inflammation in the heart reduces. The study aims to see if this existing medicine could be a helpful treatment option for this specific heart problem.
At a glance
What is this study about?
This study is investigating a condition called inflammatory cardiomyopathy. Simply put, this means your heart muscle is inflamed. When your heart muscle is inflamed, it might not pump blood as effectively as it should. This can sometimes lead to symptoms like feeling tired, short of breath, or having an irregular heartbeat. The good news is that researchers are constantly looking for better ways to manage and treat these conditions.
In this particular study, doctors are looking at a medicine called colchicine. This medicine is already used for other inflammatory conditions. The main aim of this study is to see if colchicine can help people with inflammatory cardiomyopathy. They want to find out if taking this medicine can stop the heart condition from getting worse and actually lead to improvements in heart health over a period of six months.
To do this, they will carefully monitor participants to see if the medicine helps in various ways. For example, they'll check if the heart's pumping ability improves, if there are fewer problems with irregular heartbeats, or if scans show that the inflammation in the heart is settling down. This type of study, called a Phase III trial, is often done to confirm if a new or existing treatment is effective and safe before it can be more widely used.
Key takeaways
- The study is about a heart condition called inflammatory cardiomyopathy.
- It's testing a medicine called colchicine to see if it helps.
- The goal is to prevent the condition from worsening and improve heart health.
- Participants will take a tablet for six months.
- Regular health checks will be done during the study.
Who may be eligible?
This study is open to adults aged 18 years and older. There is no upper age limit, so people of all adult ages can potentially take part. Both men and women are welcome to participate.
To be considered for this study, you would need to have a diagnosis of inflammatory cardiomyopathy. This means doctors have already identified that you have inflammation in your heart muscle.
Further checks will be done by the study doctors to make sure the study is a good fit for you and that taking part would be safe based on your specific health situation.
- Are you 18 years old or older?
- Do you have a diagnosis of inflammatory cardiomyopathy?
- Are you able to attend regular appointments for six months?
- Are you willing to take a study tablet (which could be the medicine or a dummy pill)?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you join this study, you would be given a tablet to take. This tablet is either colchicine (in 1mg or 0.5mg doses) or a dummy pill (placebo). The tablets contain ingredients like lactose, sucrose, and magnesium stearate.
You would have regular visits over six months. At these visits, doctors would do various tests to check your heart health. These checks might include blood tests, heart scans (like echocardiograms or MRI scans), and monitors to track your heart's rhythm. The study aims to see how your condition changes over this six-month period while you are taking the study medicine or dummy pill.
Potential risks and benefits
Locations (1)
- —Italy
Common questions
What is inflammatory cardiomyopathy?
It's a condition where the heart muscle becomes inflamed, which can make it harder for your heart to pump blood effectively.
What is colchicine?
It's a medicine that helps reduce inflammation, and it's being tested to see if it can help with heart inflammation.
Will I know if I'm getting the real medicine or a dummy pill?
No, this is a 'single-blinded' study, meaning you won't know if you're taking colchicine or a dummy pill, but the study team will know.
How long will I be in the study?
You will be in the study for six months, with regular checks during this time.
What kind of tests will I have?
You might have blood tests, heart scans like echocardiograms or MRI, and monitors to check your heart rhythm.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.